AVANIR INITIATES PHASE III CLINICAL TRIAL OF NEURODEX.
Biotech Business › Vol. 18 Nbr. 8, August 2005
Linked as:
Biotech Business › Vol. 18 Nbr. 8, August 2005
Linked as:Extract
AVANIR INITIATES PHASE III CLINICAL TRIAL OF NEURODEX.
AVANIR Pharmaceuticals (AMEX:AVN), San Diego., has initiatiated a double-blind, placebo-controlled, multicenter, Phase III clinical trial of Neurodex(TM) in patients...
See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Other documents:
free the bears | Break-Ins Down East Lead to Arrests of 2 Men | Critics Want to Reopen Talks On Power-Line Proposal | Sock It to Rich Guys Like Me, Buffett Says ; Don't Repeal Estate Tax, Billionaire Tells Senate Panel | sentencia nº 1398 de consiglio di stato, march 28, 2011 | Sentencia nº 656 de Consiglio di Stato February 11 2011 | sentencia nº 384 de consiglio di stato january 25 2010 | Sentencia nº 3488 de Consiglio di Stato, July 08, 2009